Drug Metabolism Reviews

Papers
(The H4-Index of Drug Metabolism Reviews is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Biotransformation research advances – 2022 year in review41
Transporter-mediated drug-drug interactions: regulatory guidelines, in vitro and in vivo methodologies and translation, special population33
Introduction to the mini special issue on next generation drug discovery and development: rethinking translational pharmacology for accelerated drug development32
International Society for the Study of Xenobiotics (ISSX) New Investigator Group Committee 2019–2020 concluding remarks26
Cutting-edge strategies and critical advancements in characterization and quantification of metabolites concerning translational metabolomics24
Metabolism of m -CPP, trazodone, nefazodone, and etoperidone: clinical and forensic aspects23
Promising role of peroxisome proliferator-activated receptors in respiratory disorders, a review19
GSTM1 and GSTT1 polymorphisms in healthy volunteers – a worldwide systematic review19
Molecular docking to investigate HLA-associated idiosyncratic drug reactions19
Insights into pharmacogenetics, drug-gene interactions, and drug-drug-gene interactions18
Deoxynivalenol and its modified forms: key enzymes, inter-individual and interspecies differences in metabolism15
The multifaceted role of cytochrome P450-Derived arachidonic acid metabolites in diabetes and diabetic cardiomyopathy14
Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms13
The annoying flaws of gerontological research13
Biopolymers as promising vehicles for drug delivery to the brain13
Biotransformation research advances – 2023 year in review13
0.04102087020874